Rivaroxaban

Rivaroxaban- oral direct Xa inhibitor

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrilation
N Engl J Med 2011

Non inferiority trial

In July 2011, FDA approved rivaroxaban (Xarelto) for prevention of deep vein thrombosis in patients undergoing knee or hip replacement surgery.